NYMC Faculty Publications
An Updated Safety Review of the Relationship Between Atypical Antipsychotic Drugs, the Qtc Interval and Torsades De Pointe As: Implications for Clinical Use
Author Type(s)
Faculty
DOI
10.1080/14740338.2024.2392002
Journal Title
Expert Opinion on Drug Safety
First Page
1127
Last Page
1134
Document Type
Article
Publication Date
9-1-2024
Department
Medicine
Abstract
INTRODUCTION: The rising prevalence of psychiatric disorders has resulted in a significant increase in the use of antipsychotic medications. These agents may prolong the corrected QT interval (QTc), running the risk of precipitating ventricular arrhythmias, notably Torsades de Pointes (TdP). Current recommendations vary regarding the optimal approach to safe prescribing practices and QTc surveillance for antipsychotics. This review summarizes the current literature addressing these clinical concerns. AREAS COVERED: The physiologic basis of the QTc interval, mechanisms underlying its susceptibility to pharmacological influence, specific risks associated with atypical antipsychotic agents, and recommendations for safe prescription practices. We performed a literature review using Pubmed and Embase databases, searching for 'antipsychotics' and 'torsades de pointes.' EXPERT OPINION: Finding a safe and universally accepted protocol for prescribing antipsychotics remains a persistent challenge in medicine. Predictive models that integrate clinical history with demographic and ECG characteristics can help estimate an individual's susceptibility to therapy-associated risks, including QTc prolongation. Agents such as ziprasidone and iloperidone are significantly more likely to prolong the QTc interval compared to others such as brexpiprazole, cariprazine, olanzapine, and clozapine. A personalized approach using low-risk medications when clinically feasible, and at the lowest efficacious dose, offers a promising path toward safer antipsychotic prescribing.
Recommended Citation
Melo, L., Pillai, A., Kompella, R., Patail, H., & Aronow, W. S. (2024). An Updated Safety Review of the Relationship Between Atypical Antipsychotic Drugs, the Qtc Interval and Torsades De Pointe As: Implications for Clinical Use. Expert Opinion on Drug Safety, 23 (9), 1127-1134. https://doi.org/10.1080/14740338.2024.2392002